Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Same-visit Hepatitis C Testing and Treatment to Accelerate Cure Among People Who Inject Drugs: a Cluster Randomised Control Trial (The QuickStart Study)

NCT05016609 is registered in ClinicalTrials.gov with Macfarlane Burnet Institute for Medical Research and Public Health Ltd as lead sponsor.

NCT NCT05016609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05016609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Same-visit Hepatitis C Testing and Treatment to Accelerate Cure Among People Who Inject Drugs: a Cluster Randomised Control Trial (The QuickStart Study)
Lead sponsor
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
March 9, 2022
Completion date
June 30, 2024
Enrollment
1,800 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c